drugset / Trial / NCT04951232

Clinical Study of Cinepazide Maleate Injection in the Treatment of Acute Ischemic Stroke

NCT04951232

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter, randomized, double-blind, placebo-controlled, parallel controlled, post marketing confirmatory clinical trial in Chinese patients with acute ischemic stroke. Objective to evaluate the efficacy and safety of cinepazide maleate injection compared with placebo in the treatment of patients with acute ischemic stroke.

Timeline

Start
2016-07-04
Primary completion
2017-01-06
Completion
2017-01-06

Drugs

EvaluationDrugModalityDoseRoute
Subject cinepazide Small molecule 320 mg Intravenous

Indications